The University of Minnesota is expanding access to clinical trials and supporting the health research community by sharing its clinical trial resource, StudyFinder, with other institutions designated with Clinical and Translational Science Awards (CTSA), a program spearheaded by the National Institutes of Health (NIH). StudyFinder is an online tool pooling clinical trials and research studies in one space, with easy-to-understand language and functions. It helps patients and healthy volunteers get involved and allows researchers to publicize their clinical trials and connect with study volunteers.
open source coding
See the following -
Alangi Derick: Wikimedia’s First African Contributor to Google Summer of Code
Alangi Derick comes from Buea, Cameroon. He joined the Wikimedia movement to develop his skills in coding, and was quickly hooked by the movement’s values and its community culture, eventually becoming a staunch advocate for it in his university. As a computer science student at the time, he joined the movement a year and a half ago, and his work booked him a place at the 2016 Google Summer of Code as one of the Wikimedia Foundation’s students. Derick passed the program, helped mentor teenage participants in Google Code-in for two consecutive years, and has helped fix bugs in the MediaWiki software...
- Login to post comments
Open Source Machine Learning Tool Could Help Choose Cancer Drugs
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails? That's where Georgia Institute of Technology researchers believe their new open source decision support tool could come in. Using machine learning to analyze RNA expression tied to information about patient outcomes with specific drugs, the open source tool could help clinicians chose the chemotherapy drug most likely to attack the disease in individual patients. In a study using RNA analysis data from 152 patient records, the system predicted the chemotherapy drug that had provided the best outcome 80 percent of the time.
- Login to post comments
Open-source Code Leads to the Adoption of University of Minnesota's StudyFinder by Additional Translational Medicine Research Institutions
- Login to post comments